Veklury, Pulver für Konzentrat zur Herstellung einer Infusionslösung

7680680260012 CH-68026 Pulver
Veklury, Pulver für Konzentrat zur Herstellung einer Infusionslösung
Veklury, Pulver für Konzentrat zur Herstellung einer Infusionslösung
Veklury, Pulver für Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Pulver
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
20/08/2025
Summary of Product Characteristics
Français
20/08/2025
Summary of Product Characteristics
Italien
20/08/2025

Detailed composition

Substance Quantity Type Category
PRC
100.0 MG Substance Wirkstoff (Principe actif)
PRC
3.146 G Substance HBESI
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
211.8 MG Substance HBESI

Reimbursement information

Public price
CHF 430.25
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2022

Authorization holder

Gilead Sciences Switzerland Sàrl

6300 Zug

Authorization information

Swissmedic authorization number
68026
Drug name
Veklury, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Galenic form
PULPI
ATC Code
J05AB16
Authorization status
Z
Dispensing category
A
First authorization
25/11/2020
Authorization expiration date
31/12/2027
IT Number
08.03.0.
Domain
Human medicine
Field of application
Corona virus disease 2019 (COVID-19)

Package details

Description (FR)
VEKLURY subst sèche 100 mg flac
Description (DE)
VEKLURY Trockensub 100 mg Durchstf
Market launch
25/11/2020
Narcotic (BTM)
No